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2National Survey on Drug Use and Health (NSDUH)
• NSDUH is a comprehensive household interview survey of substance use, 
substance use disorders, mental health, and the receipt of treatment services for 
these disorders in the United States.
• NSDUH is collected face-to-face by field interviewers who read less sensitive 
questions to respondents and transition respondents to audio computer assisted 
self-interviewing for sensitive items.
• NSDUH covers the civilian, noninstitutionalized population, aged 12 or older:
• Includes: Households, college dorms, homeless in shelters, civilians on 
military bases 
• Excludes: Active military, long-term hospital residents, prison populations, 
homeless not in shelters
• Sample includes all 50 states and DC
• Approximately 67,500 persons are interviewed annually
• Data collected from January to December 
3How Do We Use NSDUH?
• Provides a window into the state of substance use and mental 
health issues in the United States
• Helps to guide policy directions in addressing: 
• problem substances
• prevalence of mental illness
• intersection of substance use and mental health issues
• provides insights that can be studied in the context of data 
from other agencies to help in decision-making about what 
types of resources are needed and where resources should be 
directed
4Mental Illness and Substance Use Disorders in America
5Alcohol Use
6Alcohol Use Disorder
7Summary: Alcohol Use in 2019
• Past month alcohol use and past year alcohol use disorder remained stable in all age 
groups during 2018-2019
• Alcohol use and Alcohol Use Disorder declined significantly in young adults from 2016 
to 2019.
• SAMHSA will continue its prevention programs:
• SAMHSA Prevention Technology Transfer Centers produce resources and materials 
related to alcohol misuse prevention
• CSAP ‘Talk They Hear You’ focuses on underage drinking
• CSAP requires Partnerships for Success grantees to emphasize underage drinking 
prevention
• CSAT has promoted SBIRT for alcohol use in all programs including CJ, PPW, 
adolescent treatment, HIV and homeless programs 
• CSAT has funded SBIRT training in medical residencies and other healthcare 
practitioner programs which screen for hazardous alcohol use and use disorders
8Illicit Drug Use:  Major Concerns: Opioids, Marijuana, 
Methamphetamines
9Progress on the Opioid Epidemic: Prescription Pain Reliever Misuse 
10
Opioid Misuse
11
Prescription Pain Reliever Misuse and Heroin Use
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Prescription Pain Reliever Misuse
13
Sources Where Pain Relievers Were Obtained for Most Recent Misuse 
among People Who Misused Prescription Pain Relievers
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Misuse of Prescription Opioid Subtypes
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Heroin Use: Continuing to Decline in 18-25 y.o.
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Heroin-Related Opioid Use Disorder
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Opioid Use Disorder
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Treatment Gains: Number of Individuals Receiving 
Pharmacotherapy for Opioid Use Disorder (MAT)
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Summary: Opioid Misuse in the United States in 2019 Compared to 2018 
• Opioid use disorder decreased significantly from 2.0M to 1.6M. Efforts to increase 
access to Medication-Assisted Treatment, psychosocial and community recovery 
supports have had a positive effect. 
• Among those aged 12+, opioid misuse decreased significantly from 2017 and for 
those 12-17, opioid misuse decreased significantly from 2018. 
• Pain reliever misuse decreased significantly from 2018 for those 12-17 years of age 
and continues trending downward for 18-25 year olds.
• Heroin initiation decreased significantly with a 57% decline from 2018. 
• Heroin use among 18-25 year olds decreased significantly from 2018.
• Despite gains opioid overdose deaths increased in 2019 by approximately 4.6% 
underscoring the risks of potent illicit synthetic opioids and need to continue to 
engage people in treatment/recovery services.
• Buprenorphine continues to be the opioid with the highest percentage of users 
acknowledging misuse of the medication. 
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Other Illicit Substances
21
Past Month Marijuana Use for All Age Groups
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Marijuana Use among Young Adults (18-25 y.o.)
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Significant Increase in Marijuana Use among Adults 26+
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Marijuana Use Disorder:  Significant Increase for 12-17 y.o.
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Past Month Substance Use among Pregnant Women
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Marijuana Use among Women by Pregnancy Status
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Daily or Almost Daily Marijuana Use among Women by Pregnancy Status
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Past Year Substance Use and Mental Health Issues among 
Pregnant Women Aged 15 to 44 by Marijuana Use Status
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Marijuana Use: Health Concerns
• Use during pregnancy may be associated with fetal growth restriction, stillbirth, preterm birth, 
and neonatal intensive care unit admission (Metz and Borgelt, 2018; Stickrath, 2019). 
• Use linked to depression/suicide: adolescents (Roberts BA, 2019), veterans (Kimbrel et al., 2018)
• Use in adolescence is associated with increased risk for psychotic disorders in adulthood and 
is linked with suicidal ideation or behavior (D’Souza et al, 2016; McHugh et al, 2017). 
• The risk for psychotic disorders increases with frequency of use, potency of the marijuana 
product, and as the age at first use decreases (NASEM, 2017).
• Use among adolescents is linked to a decline in IQ and is associated with educational drop 
out (Meier, 2012).
• Use has been linked to the development of drug use disorders including alcohol, tobacco and 
other illicit drugs (NASEM, 2017).
• Marijuana intoxication is an important cause of MVAs associated with injury and death—it is 
wrong to say that marijuana use never killed anyone (NASEM, 2017). 
• Association between state laws allowing medical marijuana and opioid overdose mortality 
reversed direction from -21% (1999-2010) to +23% (1999-2017). (Shover, et al., 2019)
• Risk of subsequent prescription opioid misuse and use disorder was increased among people 
who reported marijuana use 5 years earlier (Olfson et al., 2017)
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Cocaine Use
31
Methamphetamine Use
32
Misuse of Prescription Stimulants
33
LSD Use Among All Age Groups
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Summary: Other Substance Use in the United States in 2019 Compared to 2018
• Past month marijuana use and past year daily or almost daily marijuana use 
significantly increased in adults aged 26+
• Past year marijuana use disorder significantly increased in adolescents 
• Non-significant increase in marijuana use by pregnant women; significant increases in 
marijuana use by women 15-44
• Alcohol and tobacco use trending downward in pregnant women; but any alcohol or 
tobacco use is hazardous in pregnancy
• No change in cocaine use in all age groups
• Upward trend in methamphetamine use and significantly increased over 2016-17 in 
adults 26 and older
• Prescription stimulant misuse trending downward in those 18-25 years old
• Past year LSD use significantly increased in adolescents; non-significant increases in 
LSD use in young adults and adults 
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Polysubstance Use and Mental Illness
36
Alcohol Use Related to Other Substance Use, MDE and SMI
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Marijuana Use Related to Other Substance Use, MDE and SMI
38
Comparison of Rates of Mental/Substance Use Disorders Associated with Marijuana Use: National 
vs. Colorado Data from the National Survey on Drug Use and Health (2019)
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Opioid Misuse Related to Other Substance Use, MDE and SMI
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Methamphetamine Use Related to Other Substance Use, MDE and 
SMI
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Summary
• Polysubstance use is common—if a person is having problems with one 
substance, they are likely using and may be having problems with other 
substances
• Treatment providers must screen for and treat all substance use disorders 
and problem substance use
• Association of substance misuse and mental illness is clear—we must all do a 
better job of helping Americans understand these relationships and risks
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Mental Health
43
Serious Mental Illness (SMI) Increasing
44
Major Depressive Episodes Increased for Those Under Age 50
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Major Depressive Episodes with Severe Impairment
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Suicidal Thoughts, Plans, and Attempts Increase for Young Adults (18-25 y.o.) 
and Adults (26-49 y.o.)
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Co-Occurring 
Mental and Substance Use Disorders
48
Substance Use among Youths (12-17 y.o.) by Past Year Major 
Depressive Episode (MDE) status
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Co-Occurring Substance Use Disorder and Any Mental Illness in Adults 
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Co-Occurring Issues: Substance Use and Mental Illness among 
Adults
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Substance Use Disorder (SUD) is Associated with Suicidal 
Thoughts, Plans, and Attempts among Adults >18 y.o.
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Mental and Substance Use Disorders: High Prevalence/Huge Treatment Gaps
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Locations Where Substance Use Treatment Was Received
54
Receipt of Substance Use Treatment at a Specialty Facility and Mental Health Services in 
the Past Year among Adults Aged 18 or Older with Past Year Substance Use Disorder and 
Serious Mental Illness: 2015-2019
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Summary: Mental Health/Co-Occurring Issues in the United States in 2019
• Serious mental illness significantly increased in adults aged 18-49 y.o. between 2018 and 2019
• Major depressive episode significantly increased in all age groups (except for those aged 50+) 
between 2018 and 2019 
• Major depressive episode with severe impairment significantly increased in adolescents and 
young adults (18-25 y.o.) between 2018 and 2019
• Suicidal thoughts and behaviors significantly increased in adults 18-49 y.o. between 2009 and 
2019
• Co-occurring substance use and mental disorders are common. Adolescents have significantly 
increased rates of MDE/substance use and significant increases in mental disorders/SUDs are 
observed in adults 18-49 y.o.
• Adults with substance use disorders have significantly higher rates of suicidal thoughts and 
behaviors than those without such conditions
• Despite modest gains, the large gap in treatment need continues
• Those who do get treatment are not getting treatment for co-occurring disorders and most 
with co-occurring disorders get treatment for one disorder or no treatment at all
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2019: A Year of Some Progress, Major Concerns
• NSDUH reveals areas where we need to focus resources:
• Continuing need to address ongoing opioid epidemic to increase the gains seen
• Marijuana use significantly increased in adults aged 26+
• Marijuana use disorder significantly increased in adolescents
• LSD use significantly increased in adolescents
• Rising year over year serious mental illness in adults aged 18-49 y.o. 
• Rising year over year major depression in all age groups with increased suicidality
• Polysubstance use is pervasive among substance users
• Substance use and mental disorders are closely linked
• Severe mental illness is a risk factor for hazardous alcohol use and illicit substance 
use
• Needs in behavioral health are underscored: ongoing efforts in prevention 
of substance use disorders, improvement in substance use treatment rates 
and treatment for youth and adults with mental illness—and this needs to 
be in the context of treatment for co-occurring disorders
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How Does NSDUH Fit With Behavioral Health Needs Nationwide?
• NSDUH is a household survey
• Does not capture other populations with great mental health/substance use 
needs:
• Institutionalized populations:
• Incarcerated
• Hospitalized
• Nursing homes
• Homeless populations
• Children under age 12
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COVID-19 Effect
2019 data is all pre-COVID-19
• COVID-19 has brought: 
• Great fear of illness/death from the virus
• Fear of resuming normal life activities for fear of infection
• Neglect of one’s own health/mental health needs for fear of infection
• Loss of familiar daily structure
• Isolation
• New expectations: children at home 24/7, parents expected to become at home teachers
• Unemployment—for millions this is expected to be permanent loss of a job as businesses 
fail and close 
• Stress of trying to find employment
• Financial stress
• Inability to get medical care and follow up because such care is deemed ‘non-essential’
• Increases in domestic violence and child abuse/neglect—home is not safe for millions
• Expect substantial increases in substance use disorders, mental illness, and suicidality in all 
age groups
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We Are Already Seeing the Negative Mental Health Effects 
of COVID-19
• 1000% increase in calls to the Disaster Distress Helpline relative to same period in 2019
• Increases in proportion of ED visits related to suicide attempts in April and May relative 
to same time period in 2019—decreased in June as stay at home orders lifted and 
America began to open up again
• Increases in calls to domestic violence hotlines
• Reports of child abuse/increases in infant deaths attributed to injuries related to child 
abuse
• Increases in suicides in some areas
• Increases in opioid overdose deaths in some areas—as much as 25-50% increases over 
comparison 2019 time period—first responders in some areas concerned about 
administering nasal naloxone related to COVID-19
• Emergency housing for those leaving psychiatric hospitalization converted to COVID-
quarantine space in some areas increasing homelessness for those with SMI
• Layoff of behavioral health staff/providers without financial reserves to survive long-
term and unable to generate enough revenue to survive
• All of this portends major increases in mental/substance use disorder treatment and 
recovery service needs and potential loss of the staff and services to assist Americans 
experiencing these issues
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Costs of Untreated Mental/Substance Use Disorders
• Cost of untreated SMI: $300B/yr (NAMI); cost of drug/alcohol abuse: $600B/yr (NIDA, 2018)
• Nearly $1 Trillion in yearly costs in addition to the devastation of lives
• Loss of productivity
• Unemployment
• Disability
• Health Care Costs
• Criminal Justice Costs
All of these burdens will only increase with the addition of the stresses of COVID-19
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What Can We Do Now?
• SAMHSA must use its resources to benefit as many as possible:
• Community based treatment and recovery services
• Build on the Certified Community Behavioral Health Clinic model
• Crisis intervention services/suicide prevention resources
• Integrated mental health, substance use, general medical services
• Children’s mental health services-linkages with schools
• Keep telemedicine/telehealth in place including use of telephone where 
audio/visual is not possible and pay for these services at same rate as face-
to-face—no reduction in reimbursement because it is telemedicine
• Continue and expand as possible technical assistance and training to 
behavioral health providers—clinicians and peers
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Address Safety Issues in BH Settings Related to COVID-19
• We must think outside the box:
• This means making treatment settings/community settings safe:
• Observe social distancing
• Masks need to become the norm
• Providers should be ordering/storing PPE: masks/gloves/disinfectants/hand 
sanitizers
• Bring back behavioral health staff for face-to-face service provision and expand 
hours—evenings and weekends may need to become the norm so that smaller 
groups who can social distance can get needed in-person care
• Our patients and their families must feel confident that their loved ones can get 
necessary services safely—for the individual and for those they will come in 
contact with at home
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It’s Up to Us Now
• Let’s work as hard as we can to make decision-makers understand mental health and 
substance use needs in America—pre and post-COVID-19
• Let’s keep the virus in mind in planning and implementing our services so that we 
can safely deliver care, but we cannot ignore the overall health needs of the 
American people—that is not an option
• Let’s work to meet the mental health/substance use needs of our people:
• Restore our systems—mental health and substance use disorder services are 
‘essential services’
• Expand our treatment and community recovery support systems permanently
• Every American life is precious and every American death—regardless of the 
cause is a terrible loss
